Article: Molecular imaging as biomarker for treatment response and outcome in breast cancer.
Therapeutic advances in medical oncology
2023 Volume 15, Page(s) 17588359231170738
Abstract: Molecular imaging, such as positron emission tomography (PET), is increasingly used as biomarker to predict and assess treatment response in breast cancer. The number of biomarkers is expanding with specific tracers for tumour characteristics throughout ... ...
Abstract | Molecular imaging, such as positron emission tomography (PET), is increasingly used as biomarker to predict and assess treatment response in breast cancer. The number of biomarkers is expanding with specific tracers for tumour characteristics throughout the body and this information can be used to aid the decision-making process. These measurements include metabolic activity using [ |
---|---|
Language | English |
Publishing date | 2023-05-18 |
Publishing country | England |
Document type | Journal Article ; Review |
ZDB-ID | 2503443-1 |
ISSN | 1758-8359 ; 1758-8340 |
ISSN (online) | 1758-8359 |
ISSN | 1758-8340 |
DOI | 10.1177/17588359231170738 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.